Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
84%
Disease
84%
Cholinergic Receptor Blocking Agent
72%
Fenretinide
58%
Brain Hemorrhage
52%
Brain Ischemia
51%
Placebo
50%
Blood Stasis
48%
Non Insulin Dependent Diabetes Mellitus
45%
Fibrinolytic Agent
45%
Protein Tyrosine Phosphatase 1B
43%
Blood Clotting Factor 13
38%
Cardiovascular Disease
36%
Fibrinogen
36%
Heart Infarction
35%
Retinoic Acid
34%
Cohort Study
33%
Fluorine 18
32%
Transient Ischemic Attack
29%
Plasminogen Activator Inhibitor 1
29%
Allopurinol
29%
Atherosclerosis
29%
Low Density Lipoprotein Receptor Knockout Mouse
29%
Cross-Sectional Study
29%
Lipodystrophy
29%
Tenecteplase
29%
Alteplase
29%
Clinical Trial
26%
Insulin Resistance
25%
Retinoid
25%
Injury
24%
Receptor
23%
Fatty Liver
23%
Edema
21%
Cytokine
21%
Sodium Fluoride
21%
Mouse Model
19%
Diet Induced Obesity
19%
Fibrinogen Concentrate
19%
Comorbidity
18%
Nonalcoholic Fatty Liver
17%
Human Study
17%
Thrombus
16%
Randomized Clinical Trial
16%
Inflammation
16%
Fibroblast Growth Factor 21
16%
Metabolic Disorder
16%
Retinol
16%
Urokinase
15%
Plasminogen Activator
15%
Bleeding
14%
Ceramide
14%
Thrombosis
14%
Hypoxia
14%
Resistant Hypertension
14%
Endothelin Receptor Antagonist
14%
Adult Respiratory Distress Syndrome
14%
Aprocitentan
14%
Peripartum Cardiomyopathy
14%
Diabetes Mellitus
14%
Persimmon
14%
Anemia
14%
Parkinson's Disease
14%
Liraglutide
14%
Wound Healing
14%
Respiratory Failure
14%
Subdural Hematoma
14%
Plasmin
14%
Plasminogen
14%
Xanthine Oxidase
14%
Apolipoprotein E Knockout Mouse
14%
Serine Proteinase Inhibitor
14%
Coronavirinae
14%
Controlled Clinical Trial
14%
Congestive Heart Failure
14%
Infection Rate
14%
Metformin
14%
Brain Edema
14%
Dexamethasone
14%
Acute Heart Failure
14%
Anakinra
14%
Aortic Valve Stenosis
14%
Tocilizumab
14%
AMPA Receptor
14%
G Protein Coupled Receptor
14%
Omega-3 Fatty Acid
14%
Serotonin
14%
4 Aminobutyric Acid
14%
Diabetic Retinopathy
14%
Calcium Channel
14%
Muscle Relaxant Agent
14%
Drug Development
14%
Maleimide
14%
Antiplasmin
14%
Interleukin 1 Receptor Blocking Agent
14%
Prevalence
14%
Open-Label Trial
14%
Aortic Stenosis
14%
Heart Muscle Fibrosis
14%
Hyperalgesia
14%
Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
69%
Parasympatholytic
58%
Disease
55%
Blood Stasis
43%
Lipodystrophy
43%
Sex Difference
40%
Maturity Onset Diabetes of the Young
36%
Cardiovascular System
36%
Fibrinolysis
36%
Myocardial Infarction
35%
Cerebral Hemorrhage
35%
Blood Clot Lysis
35%
Medicine
31%
Magnetic Resonance Imaging
30%
Gene Linkage
30%
Signal Transduction
29%
Pathophysiology
29%
Placebo
29%
Protein Tyrosine Phosphatase 1B
29%
Congestive Heart Failure
29%
Testosterone 17beta Dehydrogenase
29%
Glycon
26%
Homeostasis
24%
Secondary Prevention
24%
Fibrinolysin
23%
Odds Ratio
21%
FGF21
21%
Fatty Liver
20%
Immunocompetent Cell
20%
Cohort Analysis
20%
Hazard Ratio
20%
Randomized Controlled Trial
20%
Drug Therapy
19%
Biological Marker
19%
Transient Ischemic Attack
19%
Adipose Tissue
19%
Water-Electrolyte Imbalance
19%
Combination Therapy
18%
Fenretinide
18%
Fluorine-18
17%
Sodium Fluoride
17%
Cost-Effectiveness Analysis
17%
Thrombosis
17%
Diabetes Mellitus
17%
COVID-19
16%
Tenecteplase
16%
Diet Induced Obesity
16%
Tretinoin
16%
High Fat Food
16%
Protein Tyrosine Phosphatase
16%
Lifespan
16%
Retinoid
16%
positron emission tomographic scan
16%
Body Fat
16%
Plasminogen
16%
Surgery
15%
Comorbidity
15%
Surgical Emergency
14%
4 Acetamido 4' Isothiocyanatostilbene 2,2' Disulfonic Acid
14%
Muscle Energetics
14%
Lipid Storage
14%
Frailty
14%
Serine Proteinase Inhibitor
14%
Mental Health
14%
Endothelin Receptor Antagonist
14%
Aprocitentan
14%
Peripartum Cardiomyopathy
14%
Ventral Tegmental Area
14%
Orphan Disorder
14%
Takotsubo Cardiomyopathy
14%
Nonalcoholic Fatty Liver
14%
Heart Function
14%
Anemia
14%
G Protein Coupled Receptor
14%
Sex Hormone
14%
Urokinase
14%
Parkinson's Disease
14%
Cardiology
14%
AMPA Receptor
14%
Fibrinolytic Factor
14%
Thrombus
14%
Methionine
14%
Hyperfibrinolysis
14%
Mental Health Service
14%
Fibrinogenolysis
14%
Retrospective Cohort Study
14%
Hyperglycemia
14%
Dysfibrinogenemia
14%
Subdural Hematoma
14%
Gender and Sex
14%
Prevalence
14%
Dexamethasone
14%
Antiplasmin
14%
NMR Spectroscopy
14%
Cross Sectional Study
14%
Fibrinogen
14%
Insulin Resistance
14%
Molecular Imaging
14%
Xanthine Oxidase
14%
Keyphrases
High-fat Diet
34%
Healthcare Professionals
33%
Ischemic Stroke
30%
Food Intake
30%
Clinical Model
29%
Data Linkage
29%
Linkage Study
29%
Sex Differences
29%
Anticholinergic Burden
29%
Secondary Prevention
29%
Hydroxysteroid
29%
Confidence Interval
25%
Fibrin
24%
Partial Lipodystrophy
23%
Circadian Rhythm
23%
Plasmin
21%
Fibrinolysis
21%
Nucleus Tractus Solitarius
21%
Scottish
21%
Metabolic Health
21%
Breakfast
21%
Seipin
20%
Knock-in Mouse Model
20%
Plasminogen Receptor
19%
Knockdown
18%
Stroke Outcome
18%
All-cause Mortality
18%
Scotland
18%
Acute Ischemic Stroke
18%
Whole-body
17%
Fenretinide
17%
Metabolic Disease
17%
Plasminogen Activator
16%
Plasminogen
16%
Hypothalamic Arcuate nucleus
16%
Brainstem
16%
Feeding Behavior
16%
Glycaemia
16%
Hepatocytes
16%
Weight Loss
16%
Protein Tyrosine Phosphatase 1B (PTP1B)
16%
Hepatic Steatosis
14%
Red Lettuce
14%
Red Amaranth
14%
Light Manipulation
14%
Guanidinoglycosides
14%
Health Practitioners
14%
4-HPR
14%
Emergency Surgery
14%
Synthesis Chemistry
14%
Stabilizing Force
14%
Activator Concentration
14%
Thromboinflammation
14%
Type 2 Diabetes Mellitus (T2DM)
14%
C57BL
14%
Ablation
14%
Fiber Mixture
14%
Aprocitentan
14%
Endothelin Antagonist
14%
Brilliant Red
14%
Regional Registry
14%
GLP-1 Receptor Agonist
14%
Redundant Signals Effect
14%
Lipodystrophy
14%
Nck1
14%
Macrophage Foam Cells
14%
Renaissance
14%
Myotube Growth
14%
Transient Ischemic Attack
14%
Protein-rich
14%
Imaging Studies
14%
Adipose Tissue Expansion
14%
Endogenous Fibrinolysis
14%
Altered Mental Status
14%
Hypofibrinolysis
14%
Randomized Placebo-controlled Trial
14%
Acute Heart Failure
14%
Body Fat Accumulation
14%
Immune Signaling
14%
Noninvasive Respiratory Support
14%
Cryoprecipitate Transfusion
14%
Leucine
14%
Liraglutide
14%
5-HT2CR
14%
Ethiopia
14%
Morning Exercise
14%
Fast Field Cycling
14%
Methionine Restriction
14%
Registry Data
14%
Motivation
14%
Allopurinol
14%
Tissue Health
14%
Xanthine Oxidase Inhibitor
14%
Randomized Crossover Trial
14%
Stroke Ischemic
14%
Neuropeptide Y
14%
T1 Quantification
14%
Dietary Protein
14%
Tenecteplase
14%
GABAergic Circuits
14%